Showing results (951-960 of 1,650) with videos related to

Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|October 31, 2022
Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse EventsHidetaka Kobayashi, Sayoko Fukuda, Rina Matsukawa, et al.
Therapeutic Innovation & Regulatory Science|September 13, 2022
First Approval of Generic Mometasone Furoate Nasal Suspension Spray in Japan: Similarities and Differences Between Japan and the USARyosuke Kuribayashi, Miho Kasuga, Kimika Kuwana, et al.
Therapeutic Innovation & Regulatory Science|September 14, 2022
Assessing the Financial Value of Decentralized Clinical TrialsJoseph A DiMasi, Zachary Smith, Ingrid Oakley-Girvan, et al.
Therapeutic Innovation & Regulatory Science|September 15, 2022
Implementation of a Pharmacovigilance System in a Resources-Limited Country in the Context of COVID-19: Lebanon's Success StoryHanine Abbas, Abeer Zeitoun, Myriam Watfa, et al.
Therapeutic Innovation & Regulatory Science|September 15, 2022
Influence Diagnostics of a Region of Interest in Multi-regional Clinical TrialsKazuhiko Kuribayashi, Charlie Cao
Therapeutic Innovation & Regulatory Science|September 28, 2021
Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical CompaniesGiana Carli Lorenzini, Annika Olsson
Therapeutic Innovation & Regulatory Science|February 19, 2022
Potential Future Drug Development Lag in Japan Based on an Analysis of Multiregional Clinical Trials in the US, Europe, and East AsiaAtsushi Noguchi, Hideki Hanaoka, Yoshiaki Uyama
Therapeutic Innovation & Regulatory Science|April 16, 2019
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug DevelopmentElizabeth Yen, Jonathan M Davis, Christopher-Paul Milne
Therapeutic Innovation & Regulatory Science|February 4, 2022
Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USAZhong Wang, Sharon K Ahluwalia, Bryan Newman, et al.
Therapeutic Innovation & Regulatory Science|February 7, 2022
Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?Kevin Klein, Pieter Stolk, Pär Tellner, et al.
Pageof 165